Material safety data sheet

MATERIAL SAFETY DATA SHEET
ENGEMYCIN® 100
Intervet Australia Pty Limited Box 2800 Bendigo Delivery Centre VIC 3554 Phone:

1. IDENTIFICATION
1.10
Prescription Only drug for animal treatment only - Broad spectrum antibiotic injection for use in horses, cattle, sheep, pigs, dogs and cats * Active Constituent + Confidential Manufacturing Information Chemical Characterisation: Oxytetracycline Hydrochloride Sterile Injection Sterile liquid contained in 100 mL & 250 mL multidose vials Colourless, clear yellow aqueous solution The vapour pressure of ethanolamine is low. UPO, 0.2mm 20oc See Martindale Extra Pharmacopoeia 29th ed., pages 313-322 HEALTH HAZARD INFORMATION
The oxytetracycline component may be taken as non toxic. Ethanolamine eye irritancy- 763 microgram severe Sensitization - can occur to tetracyclines but is usually limited to urticarial type rashes Eye contact - Flush eyes with copious amounts of water for at least 15 minutes. Seek medical advice. Skin contact - Flush skin for 15 minutes with copious amounts of cold water . Remove and wash contaminated clothing before reuse. Self Injection - Wash and disinfect self injection injuries. Seek medical advice if irritancy or an allergic response occurs. Accidental self injection of any tetracycline injection may cause some local irritation in humans (or even thrombo-phlebitis if given intravenously). Haemopoeitic diseases occur in humans rarely. The injection of out of date material in humans causes Fanconi type symptoms due to degradation products. The Fanconi symptoms, due to accidental self injection of out of date material, are reversible and include polyuria, polydipsia, nausea, proteinuria, glycosuria acidosis and hypocalcaemia. Treat symptomatically any allergic reaction to tetracycline or any local irritancy caused by ethanolamine. PRECAUTIONS FOR USE
Exposure Standards / Engineering Control This product is not subject to the Australian Code for the Transport of Dangerous Goods by Road and Rail. This product is a Poisons Schedule 4 prescription drug and may only be possessed and used by those people with appropriate authorisation. No special measures are required. Exercise normal care to prevent accidental self-injection. Store away from food, drink or animal feeding stuffs. Store below 25oc. Do not freeze. The product is water based and not flammable MEASURES IN CASE OF ACCIDENTS AND FIRES
Classification under the Transportation of Dangerous Goods DG storage/transport in accordance with State and Territory regulations. This product is not subject to the requirements of the Australian Code for the Transport of Dangerous Goods by Road and Rail. Product should be stored and handled in accordance with regulations governing Schedule 4 (prescription) drugs. Dispose of unused or expired material in an authorised landfill. Spillage quantities will be minor due to the small volumes product normally transported and stored. Prevent the spill spreading to contaminate other areas. Do not allow the product to contact skin or eyes. Wear rubber gloves for clean-up operations. Do not smoke or eat during clean-up operations. If contact occurs immediately wash off with soap and water. Absorb into paper towel, hydrated lime, soil or sand, depending on quantity involved. Dispose of contaminated absorbent material in an appropriate manner. Rinse area of spill with detergent and water. On completion of clean-up wash all exposed skin areas and any contaminated protective clothing. Inform the local water authority if large amounts enter the drainage system. In fire incidents toxic fumes of nitrogen oxides, sulphur oxides, carbon monoxide may be formed. Hazardous Decomposition Do not use expired, pre-used or past date material Products: Because the vapour pressure of ethanolamine is low, spillages must be cleared promptly before significant amounts of ethanolamine are volatilized. INFORMATION
There is no data on ecological effects. It is not anticipated there will be any effect on the environment as a consequence of normal use. Accidental spillage of large shipments could be a problem as the entry into sewerage treatment plants of large volumes of antibiotics may inhibit processing. Thus, disposal of large volumes into drainage sewerage system of local councils should be avoided if possible. CONTACT POINT ( For Non-Emergency Calls )
Product Safety Coordinator: Matt Playford DISCLAIMERThe Material Safety Data Sheet has been developed according to WORKSAFE Australia / NOHSC guidelines. The data, information and recommendations herein (“information”) are represented in good faith and believed to be correct as of the date hereof. The purpose of this Material Safety Data Sheet is to describe product in terms of their safety requirements. Intervet Australia Pty Limited makes no representation of merchantability, fitness for a particular purpose or application, or of any other nature with respect to the information or the product to which the information refers (“the product”). The information is supplied upon the condition that the persons receiving same will make their own determination as to its suitability for their purposes prior to use of the product. The physical data shown herein are typical values based on material tested. These values should not be construed as a guaranteed analysis of any specific lot or as guaranteed specification for the product or specific lots thereof. Due care should be taken to make sure that the use or disposal of this product is in compliance with relevant Federal, State and Local Government regulations.

Source: http://www.farrer.nsw.edu.au/angus/downloads/MSDSbeef/Engemycin.pdf

Microsoft powerpoint - cbre_viewpoint_pharma_final.171109.ppt

Global ViewPoint Global Research and Consultingwww.cbre.eu/research THE PHARMACEUTICAL SECTOR: REAL ESTATE IMPLICATIONS OF INDUSTRY-WIDE CHANGE Nick Compton, Head of Life Sciences, Global Corporate Services, EMEA INTRODUCTION As a truly global consumer of the widest range of property asset types and the most expensive buildings, the pharmaceutical sector is of significant importance to t

Microsoft word - r6199034.rtf

Safety Data Sheet Oxybutynin Hydrochloride Revision date : 2011/09/28 1. Product and Company Identification 2. Hazards Identification Emergency overview WARNING: HARMFUL IF SWALLOWED. May cause eye damage. Possible risk of harm to the unborn child. KEEP OUT OF REACH OF CHILDREN. INGESTION MAY CAUSE GASTRIC DISTURBANCES. CAN FORM EXPLOSIVE DUST-AIR MIXTURES. Avoid c

© 2010-2017 Pharmacy Pills Pdf